Monoclonal antibody helps clear psoriasisBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7589.337-b (Published 15 February 2007) Cite this as: BMJ 2007;334:337
Interleukins 12 and 23 have both been implicated in the pathogenesis of psoriasis. So scientists developed a human monoclonal antibody to disable them, and tested it in 320 volunteers with moderate or severe disease. The antibody worked well. Twelve weeks after only a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial